title: Long-survivors of glioblatoma treated with boron neutron capture therapy (BNCT).
abstract: The purpose of this study was to compare the radiation dose between long-survivors and non-long-survivors in patients with glioblatoma (GBM) treated with boron neutron capture therapy (BNCT). Among 23 GBM patients treated with BNCT, there were five patients who survived more than three years after diagnosis. The physical and weighted dose of the minimum gross tumor volume (GTV) of long-survivors was much higher than that of non-long survivors with significant statistical differences.
authors.affiliation: Department of Neurosurgery, Kagawa National Children's Hospital, Kagawa, Japan. kageji@clin.med.tokushima-u.ac.jp
authors.forename: T
authors.initials: T
authors.lastname: Kageji
authors.forename: Y
authors.initials: Y
authors.lastname: Mizobuchi
authors.forename: S
authors.initials: S
authors.lastname: Nagahiro
authors.forename: Y
authors.initials: Y
authors.lastname: Nakagawa
authors.forename: H
authors.initials: H
authors.lastname: Kumada
mesh_terms: D000328:Adult; D016754:Boron Neutron Capture Therapy; D001932:Brain Neoplasms / Q000532:radiotherapy*; D005260:Female; D005909:Glioblastoma / Q000532:radiotherapy*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D017741:Survivors